Genotyping of hepatitis C virus (HCV) in infected patients from Northeast Mexico

被引:27
作者
Maria Rivas-Estilla, Ana [2 ]
Cordero-Perez, Paula
del Carmen Trujillo-Murillo, Karina [2 ]
Ramos-Jimenez, Javier [3 ]
Chen-Lopez, Carlos
Garza-Rodriguez, Maria de L. [2 ]
Ramirez-Gutierrez, Angel
Munoz-Espinosa, Linda [1 ]
机构
[1] Autonomous Univ Nuevo Leon, Sch Med, Dept Internal Med, Liver Unit, Monterrey, Nuevo Leon, Mexico
[2] Autonomous Univ Nuevo Leon, Sch Med, Dept Biochem, Monterrey, Nuevo Leon, Mexico
[3] Autonomous Univ Nuevo Leon, Sch Med, Infect Dis Serv, Monterrey, Nuevo Leon, Mexico
关键词
hepatitis C virus (HCV); HCV genotype; HCV-RNA; prevalence; Northeast Mexico; blood transfusion;
D O I
10.1016/S1665-2681(19)31870-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Information about HCV genotypes in infected patients from-different regions of Mexico is limited. Objective: To determine the prevalence of HCV genotypes in a group of HCV infected patients who attended a third level Hospital in Northeast of Mexico. Methods: Genotyping analysis was performed using the InnoLiPAHCV genotype assay in 147 patients (65 males and 82 females, mean age 44 +/- 12 years) with positive anti-HCV antibodies and detectable HCV-RNA levels. Results: Infected individuals were more likely to be female (56%). Histological data showed that 63% of the patients had chronic. hepatitis, while the remainder presented cirrhosis (37%). T he most frequent HCV genotype was 1 (73%). We found the following distribution: genotype 1 (2.7%), 1a (28.6%), 1b (37.4%), 1a/1b (4.1%), 2a (1.4%), 2b (8.8%), 2c (0.7%), 2a/2c (2.7%), 3 (2%),3a (10.2%),4 (0.7%) and 4c (0.7%). The most frequent associated risk factor was blood transfusion (72.5%). Conclusion: Prevalence of HCV genotypes in the-Northeast of Mexico is similar to those reported previously in other Mexican regions and the most frequent risk factor continues being blood transfusion.
引用
收藏
页码:144 / 147
页数:4
相关论文
共 22 条
[1]   Hepatitis C virus infection in the United States [J].
Alter, MJ .
JOURNAL OF HEPATOLOGY, 1999, 31 :88-91
[2]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[3]   Prevalence of hepatitis C virus genotypes in a Mexican population [J].
Cital-Zamora, JL ;
Navarrete-Castro, R ;
Magaña-Muñoz, KD ;
Martinez-Rodríguez, ML ;
Calderon, GM .
ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (05) :607-607
[4]  
DELEON LV, 2005, REV GASTROENTEROL ME, V70, P25
[5]   Optimal therapy of hepatitis C [J].
Di Bisceglie, AM ;
Hoofnagle, JH .
HEPATOLOGY, 2002, 36 (05) :S121-S127
[6]  
GuerreroRomero JF, 1996, SALUD PUBLICA MEXICO, V38, P94
[7]  
HERNANDEZPEREZ RE, 1994, SALUD PUBLICA MEXICO, V36, P538
[8]  
Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35
[9]  
Méndez-Sánchez N, 2007, ANN HEPATOL, V6, P279
[10]   Distribution of HCV genotypes among different exposure categories in Brazil [J].
Oliveira, MLA ;
Bastos, FI ;
Sabino, RR ;
Paetzold, U ;
Schreier, E ;
Pauli, G ;
Yoshida, CFT .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (03) :279-282